SCHEMBL322235

SCHEMBL322235

CCOC(C)Oc1cc[c]cc1

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42
NQO1 P15559 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3852488 0.85 LMNA (0.52) LMNANQO1
SCHEMBL8022244 0.85
SCHEMBL7931483 0.84 GAA (0.32)
SCHEMBL991828 0.82 TSHR (0.35)
SCHEMBL9674064 0.79
SCHEMBL997422 0.79 LMNA (0.46) LMNA
SCHEMBL4059616 0.79 LMNA (0.46) LMNANQO1
SCHEMBL991314 0.79 NR5A1 (0.38) LMNA
SCHEMBL1607620 0.79 TAS1R3 (0.31)
SCHEMBL14009524 0.78 LMNA (0.44) LMNANQO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1576032-B1 TRICYCLIC ARYLAMINE MONOMER AND POLYMERS AND DEVICES THEREOF DOW GLOBAL TECHNOLOGIES INC (US) 2007-10-17 EP claimed
EP-1576032-A1 TRICYCLIC ARYLAMINE MONOMER AND POLYMERS AND DEVICES THEREOF Dow Global Technologies Inc. (US) 2005-09-21 EP claimed
WO-2004060970-A1 TRICYCLIC ARYLAMINE MONOMER AND POLYMERS AND DEVICES THEREOF DOW GLOBAL TECHNOLOGIES INC. (US) 2004-07-22 WO claimed
US-6124332-A AN ENZYME INHIBITOR FOR THE TREATMENT OR PROPHYLAXIS OF TISSUE BREAKDOWN, FOR EXAMPLE RHEUMATOID ARTHRITIS, OSTEOPOROSIS, PERIODONTITIS, GINGIVITIS, CORNEAL EPIDERMAL OR GASTRIC ULCERATION, AND TUMOR, MULTIPLE SCLEROSIS BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2000-09-26 US claimed
US-6022898-A ALPHA-SULFONYLAMINO-SUBSTITUTED HYDROXAMIC ACIDS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2000-02-08 US claimed
EP-0766665-B1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARM (GB) 1999-07-28 EP claimed
US-5847218-A Sulfonium salts and chemically amplified positive resist compositions SHIN-ETSU CHEMICAL CO., LTD. (JP) 1998-12-08 US claimed
EP-0766665-A2 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1997-04-09 EP claimed
EP-0766664-A2 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1997-04-09 EP claimed
WO-1995035276-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1995-12-28 WO claimed
WO-1995035275-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1995-12-28 WO claimed
US-20230152699-A1 FILM-FORMING COMPOSITION NISSAN CHEMICAL CORPORATION (JP) 2023-05-18 US disclosed
CN-109843853-A The manufacturing method of composition and the equipment using the composition 东洋合成工业株式会社 2019-06-04 CN disclosed
EP-1923418-B1 STAR POLYMER AND PROCESS FOR PRODUCTION THEREOF NIPPON SODA CO (JP) 2016-11-09 EP disclosed
US-9464167-B2 Poly α-amino acid and ferroelectric memory element using same AJINOMOTO CO., INC. (JP) 2016-10-11 US disclosed
WO-1995035276-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1995-12-28 WO disclosed
US-5278148-A Hypotensive agents HOFFMANN-LA ROCHE INC. (US) 1994-01-11 US disclosed
US-5140011-A Hypotensive agents HOFFMANN-LA ROCHE, INC. (US) 1992-08-18 US disclosed
US-4570005-A REACTING THE ARYL PROPYL CHLORIDE WITH THE CORRESPONDING ARYL ALCOHOL OR ARYL MERCAPTAN MITSUITOATSU CHEMICALS INC. (JP) 1986-02-11 US disclosed
US-4397864-A LOW TOXICITY MITSUITOATSU CHEMICALS INC. (JP) 1983-08-09 US disclosed